Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 2

1(25.0%)

4Total

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07424092Phase 2Not Yet Recruiting

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

Role: collaborator

NCT04583124Not ApplicableCompleted

Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)

Role: collaborator

NCT05497973Not ApplicableUnknown

Psychosocial eHealth in Advanced Lung Cancer

Role: collaborator

NCT04379908Completed

Healthy Lifestyles and Quality of Life in Women With Breast Cancer

Role: collaborator

NCT05078216Completed

How to Carry on an Effective Community Program of Exercice-oncology.

Role: lead

NCT02900911Not ApplicableCompleted

Swallowing Rehabilitation in Patients With Head and Neck Cancer Receiving Radiotherapy

Role: collaborator

All 6 trials loaded